SAHPRA - Relevance of the New South African Health Products Regulatory Authority and Opportunities Ahead

Authors

Keywords:

SAHPRA, MCC, South Africa, Challenges, Opportunities, Collaboration, Coordination

Abstract

Regulatory environments are constantly evolving, and South Africa has witnessed some significant developments in the recent past. Operational launch of the South African Health Products Regulatory Authority (SAHPRA) as new healthcare products regulator marks a key milestone in the establishment of international standards in regulatory practices. Both the Medicines Control Council (MCC) and the Directorate of Radiation Control (DRC) were replaced by SAHPRA to bring control of medicines, medical devices, in vitro diagnostic tests and devices, and radiation emitting products under one regulatory body. The new agency was instituted under schedule 3A of Public Finance Management Act as public entity, thereby enabling it to retain the revenue generated. The change has evidently impacted the regulatory practices positively; however, the challenges inherited by regulators and those regulated are enormous. SAHPRA needs to confront the challenges and make the most out of the opportunities ahead. This study aims to focus on understanding the new agency, its evolution over time, objectives set forth, organizational and operational construct, responsibilities, accomplishments so far, outstanding challenges, opportunities ahead, and the collaborative efforts that can support its operation. SAHPRA has had noteworthy achievements as a healthcare products regulator. By making most use of collaboration efforts SAHPRA is all set to work through the challenges and gain from opportunities.

https://doi.org/10.21423/jrs-v09i2dureja

References

African Union Development Agency. (n.d.). African Medicines Regulatory Harmonisation (AMRH). Retrieved April 5, 2020 from https://nepad.org/programme/african-medicines-regulatory-harmonisation-amrh

African Union Development Agency. (n.d.). AUDA-NEPAD: Who We Are. Retrieved April 5, 2020 from https://nepad.org/who-we-are/about-us

Belseck, N. (2020, February). Health products regulation in 2020. Medical Chronicle. Retrieved April 5, 2020 from https://www.sahpra.org.za/sahpra-ceo-interview/sapra-chair-interview/

Belseck, N. (2020, February). SAHPRA's new CEO. Medical Chronicle. Retrieved April 5, 2020 from https://www.sahpra.org.za/sahpra-ceo-interview/ceo-interview/

Burnett, M. (2019, May 27). Rescheduling of medicines and exclusions to certain provisions of the medicines act include a change to status of cannabidiol. FASKEN. Retrieved April 18, 2020 from https://www.fasken.com/en/knowledge/2019/05/rescheduling-of-medicines-and-exclusions-to-certain-provision/

European Directorate for the Quality of Medicines and Healthcare. (n.d.). Which countries accept certificates of suitability?. EDQM FAQs. Retrieved April 5, 2020 from https://faq.edqm.eu/pages/viewpage.action?pageId=1377018

Fields of Green for All. (2019, February 5). Do you still want a license to grow cannabis? Retrieved April 5, 2020 from https://fieldsofgreenforall.org.za/do-you-still-want-a-license-to-grow-cannabis/

Fix The Patent Laws. (2019, April 24). Tuberculosis innovation approaches in South Africa and strategies to secure public returns. Retrieved April 5, 2020 from https://www.fixthepatentlaws.org/tuberculosis-innovation-approaches-in-south-africa-and-strategies-to-secure-public-returns/

Freyr Solutions. (n.d.). The Health Authority Face-Lift: China and South Africa. Retrieved April 5, 2020 from https://www.freyrsolutions.com/blog/the-health-authority-face-lift-china-and-south-africa

GBI Research. (2012, June). Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process. Retrieved April 18, 2020 from http://www.gbiresearch.com/report-store/market-reports/archive/emerging-pharmaceutical-market-south-africa-proposed-introduction-of-new-drug-regulatory-agency-(sahpra)-to-accelerate-drug-r/figures

Guirguis, R., Woods, T., & Lissalde-Bonnet, G. (2018, May 9). Government and regulatory body ThinkTank: Discussing the possibility of regulatory alignment across Africa} [Presentation]. Presented at the GS1 Healthcare African Conference, Addis Ababa, Ethiopia. Retrieved April 18, 2020 from https://www.gs1.org/sites/default/files/docs/addisababa/PresentationDay2/20180508.%20Addis_Day2_ThinkTank%20ONLINE.pdf

Griffiths, S., Ahmar, S., Seager, J., Simbayi, L., & Mbelle, N. (2014, April). Mid-Term Evaluation of the SARRAH programme. Retrieved April 5, 2020 from https://www.oecd.org/derec/unitedkingdom/Mid-term-Evaluation-SARRAH-Programme.pdf

International Council for Harmonisation. (2020). Current members and observers. Retrieved April 5, 2020 from https://www.ich.org/page/members-observers

International Pharmaceutical Regulators Programme. (n.d.). IPRP Strategic Vision 2018 - 2020. Retrieved April 5, 2020 https://admin.iprp.global/sites/default/files/2018-08/IPRP_StrategicVision_Final_2018_0716.pdf

International Pharmaceutical Regulators Programme. (n.d.). Members & Observers. Retrieved April 5, 2020 http://www.iprp.global/members

International Pharmaceutical Regulators Programme. (n.d.). Mission. Retrieved April 5, 2020 http://www.iprp.global/page/mission

International Pharmaceutical Regulators Programme. (2019). External Stakeholder Engagement Plan. Retrieved April 5, 2020 from https://admin.iprp.global/sites/default/files/2019-06/IPRP_StakeholderEngagementPlan_V1-1_2019_0602.pdf

World Health Organization. (2019, June 3). Reliance - Analysis of responses to WHO questionnaire - an update [Presentation]. Presented at International Pharmaceutical Regulators Programme, Amsterdam, the Netherlands. Retrieved April 5, 2020 from https://admin.iprp.global/sites/default/files/2019-06/IPRP_Reliance_WHOSurveyOutcomes_2019_0618.pdf

IPRP Overview [Presentation]. (2020, June). Retrieved April 5, 2020 from https://admin.iprp.global/sites/default/files/2020-06/IPRP_Overview_2020_0605.pdf

Keele, M. G., & Oliver, D. W. (2019, January/February). South African Pharma Industry: Workforce Appraisal & Proposed Development Strategy. Retrieved April 18, 2020 from https://ispe.org/pharmaceutical-engineering/january-february-2019/south-african-pharma-industry-workforce-appraisal-proposed-development

Keyter, A., Banoo, S., Salek, S., & Walker, S. (2018). The South African Regulatory System: Past, Present, and Future. Frontiers in Pharmacology, 2018(9). https://www.doi.org/10.3389/fphar.2018.01407

Keyter, A., Gouws, J., Salek, S., & Walker, S. (2018). The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System. Therapeutic Innovation & Regulatory Science, 52(4), 449-458. https://www.doi.org/10.1177/2168479018776649

Keyter, A., Salek, S., Gouws, J., Banoo, S., & Walker, S. (2020). Evaluation of the Performance of the South Africa Regulatory Agency: Recommendations for Improved Patients' Access to Medicines. Therapeutic Innovation & Regulatory Science, 54(4), 878-887. https://www.doi.org/10.1007/s43441-019-00013-5

Krebs, Mandi. (2018, May 9). The evolution of CBD in South Africa. Retrieved April 18, 2020 from https://www.engage.hoganlovells.com/knowledgeservices/news/the-evolution-of-cbd-in-south-africa

Rogers, I., & Langbridge, S. (2016, February 29). Meet SAHPRA - New Regulator of Medices, Medical Devices and IVDs. Retrieved April 18, 2020 from https://www.lexology.com/library/detail.aspx?g=b47d21e3-0d2e-4137-b298-538f4b027ee7

Mahlatji, M. D. (2018, December 9). Medicines Registration: SAHPRA [Presentation]. Presented at the Global Regulatory Workshop for Pharmerging Market, Seoul, South Africa. Retrieved April 18, 2020 from https://www.nifds.go.kr/brd/m_95/down.do?brd_id=board_mfds_411&seq=30934&data_tp=A&file_seq=2

New body to take over from MCC in 2017. (2016, January 26). Medical Brief. Retrieved April 18, 2020 from https://www.medicalbrief.co.za/archives/new-body-to-take-over-from-mcc-in-2017/

Department aims to launch new health products watchdog next year. (2016, January 22). Doctor's Portal. Retrieved April 18, 2020 from https://doctorsportal.mediclinic.co.za/Lists/News/DoctorsDispForm.aspxID=1259&ContentTypeId=0x010057A3FE46DA122B48A1BA84CA4F16E388

Mehta, U., Kalk, E., Boulle, A., Nkambule, P., Gouws, J., Rees, H., & Cohen, K. (2017). Pharmacovigilance: A public health priority for South Africa. South African Health Review, 2017, 125-133.

Omarjee, J-H., Germishuizen, W. A., Chetty, R., & Stubbings, D. (2018). Plasma fractionation in South Africa: Challenges and successes in meeting international standards. Annals of Blood, 3(1).

Parliamentary Monitoring Group. (2010, November 9). Directorate of Radiation Control Unit & South African Medical Association briefings. Retrieved April 18, 2020 from https://pmg.org.za/committee-meeting/12341/

Parliamentary Monitoring Group. (2014, October 29). Medicines & Related Substances Amendment Bill [B6-2014]: public hearings day 1. Retrieved April 18, 2020 from https://pmg.org.za/committee-meeting/17763/

Pharma Boardroom. (n.d.). Interview: Tanya Vogt - Executive Officer, The South African Medical Device Industry Association (SAMED). Retrieved April 18, 2020 from https://pharmaboardroom.com/interviews/interview-tanya-vogt-executive-officer-the-south-african-medical-device-industry-association-samed/

Pharma Boardroom. (2018, December 10). Cannabinoid Drugs and Medicinal Cannabis. Retrieved April 5, 2020 from https://pharmaboardroom.com/legal-articles/cannabinoid-drugs-and-medicinal-cannabis-south-africa/

Pharma Boardroom. (2018, December 10). Marketing, Manufacturing, Packaging & Labelling, Advertising. Retrieved April 5, 2020 from https://pharmaboardroom.com/legal-articles/marketing-manufacturing-packaging-labelling-advertising-south-africa/

Pharma Boardroom. (2018, December 10). Preclinical & Clinical Trial Requirements. Retrieved April 5, 2020 from https://pharmaboardroom.com/legal-articles/preclinical-clinical-trial-requirements-south-africa/

Pharma Boardroom. (2018, December 10). Product Liability. Retrieved April 5, 2020 from https://pharmaboardroom.com/legal-articles/product-liability-south-africa/

Pharma Boardroom. (2018, December 10). Regulatory, Pricing and Reimbursement}. Retrieved April 5, 2020 from https://pharmaboardroom.com/legal-articles/regulatory-pricing-and-reimbursement-south-africa/

Pharma Boardroom. (2018, December 10). Regulatory Reforms. Retrieved April 5, 2020 from https://pharmaboardroom.com/legal-articles/regulatory-reforms-south-africa/

Pharma Boardroom. (2018, December 10). Traditional Medicines & OTC Products. Retrieved April 5, 2020 from https://pharmaboardroom.com/legal-articles/traditional-medicines-otc-products-south-africa/

Roelf, W. (2018, April 9). South Africa may ask pharma firms for fee to clear drug review backlog. Reuters. Retrieved April 5, 2020 from https://www.reuters.com/article/us-safrica-pharmaceuticals/south-africa-may-ask-pharma-firms-for-fee-to-clear-drug-review-backlog-idUSKBN1HG15I

Roth, L., Bempong, D., Babigumira, J. B., Banoo, S., Cooke, E., Jeffreys, D., Kasonde, L., Leufkens, H. G. M., Lim, J. C. W., Lumpkin, M., Mahlangu, G., Peeling, R. W., Rees, H., Ndomondo-Sigonda, M., Stergachis, A., Ward, M., & Nwokike, J. (2018). Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems. Global Health, 14(102). https://www.doi.org/10.1186/s12992-018-0421-2

Sithole, T., Mahlangu, G., Salek, S., & Walker, S. (2020). Evaluating the Success of ZaZiBoNa, the Southern African Development Community Collaborative Medicines Registration Initiative. Therapeutic Innovation & Regulatory Science, 54(2020), 1319-1329. https://www.doi.org/10.1007/s43441-020-00154-y

Southern African Development Community. (n.d.). SADC Overview. Retrieved August 25, 2020 from https://www.sadc.int/about-sadc/overview/

South African Health Products Regulatory Authority. (n.d.). About Us. Retrieved April 18, 2020 from https://www.sahpra.org.za/who-we-are/

South African Health Products Regulatory Authority. (n.d.). Backlog Clearance Project. Retrieved April 5, 2020 from https://www.sahpra.org.za/backlog/

South African Health Products Regulatory Authority. (n.d.). Regulatory Partnership. Retrieved April 5, 2020 from https://www.sahpra.org.za/regulatory-partnership/

South African Health Products Regulatory Authority. (n.d.). What is codeine? Retrieved April 5, 2020 from https://www.sahpra.org.za/what-is-codeine/

South African Health Products Regulatory Authority. (n.d.). SAHPRA responds to coronavirus (COVID-19): Medicines/medical devices supply challenges. Retrieved April 5, 2020 from http://www.sahpra.org.za/wp-content/uploads/2020/03/Report-Shortages_FINAL_17March.pdf

South African Health Products Regulatory Authority. (2007, September). Medicine Safety Alert: Promethazine Contraindicated in Children Under Two Years of Age. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2019/10/MSA-promethazine-1.pdf

South African Health Products Regulatory Authority. (2016, September). eCTD Go-live in South Africa. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/8d6a0b529.80_eCTD_go_live_Sept16_v1.pdf

South African Health Products Regulatory Authority. (2016, November 9-10). ICH Press Release. Osaka, Japan. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/55a96f32ICHPressrelease.pdf

South African Health Products Regulatory Authority. (2016, November 25). Press Release: Medicines Control Council Clarifies Access to Cannabis for the Treatment of Medical Conditions. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/7f8b4f3410.14_Media_Release_Cannabis_Nov16_v1.pdf

South African Health Products Regulatory Authority. (2018, February 12). Appointment of the South African Health Products Regulatory Authority (SAHPRA) Board. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/SAHPRA_Press_Release_February_2018.pdf

South African Health Products Regulatory Authority. (2018, March). Strategic Plan for the Fiscal Years, 2018/19 - 2022/23. Retrieved April 5, 2020 from https://www.hpasa.co.za/wp-content/uploads/2018/06/SAHPRA-Strategic-Plan-2018-19-to-2022-23.pdf

South African Health Products Regulatory Authority. (2019, May). Questions & Answers: Implementation of eCTD in South Africa. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/b673d42b2.28_eCTDQA_May19_v4.pdf

South African Health Products Regulatory Authority. (2019, May 8). Who or What is SAHPRA? Retrieved April 5, 2020 from https://www.mm3admin.co.za/documents/docmanager/editor/9400/UserFiles/who%20is%20sahpra.pdf

South African Health Products Regulatory Authority. (2019, May 15). Backlog Clearance Program - Newsletter Update. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/SAHPRA-Backlog-Clearance-Program-Monthly-Industry-Update-2019_05.pdf

South African Health Products Regulatory Authority. (2019, June 27). Backlog Clearance Program Newsletter. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/SAHPRA-Backlog-Clearance-Program-Newsletter-2019_06.pdf

South African Health Products Regulatory Authority. (2019, August 1). Backlog Clearance Program Newsletter. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/SAHPRA-Backlog-Clearance-Program-Newsletter-2019_08.pdf

South African Health Products Regulatory Authority. (2019, September 19). SAHPRA Annual Report 2018/19. Retrieved April 5, 2020 from http://www.sahpra.org.za/wp-content/uploads/2020/03/K-15344-SAHPRA-AR-2018-19-Dev-16-Interactive-Amended.pdf

South African Health Products Regulatory Authority. (2019, October 13). Backlog Clearance Program Newsletter. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/SAHPRA-Backlog-Clearance-Program-Industry-Newsletter-31-October-2019.pdf

South African Health Products Regulatory Authority. (2019, November). Proprietary Names for Medicines. Retrieved April 18, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/02/2.15-Proprietary-Names-Guideline_v6_Nov2019-2.pdf

South African Health Products Regulatory Authority. (2019, November). SA Guide to Good Manufacturing Practice for Medicines. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/02/4.01_SA_Guide_to_GMP_Dec17_v6-final-Nov-2019-1.pdf

South African Health Products Regulatory Authority. (2020, January). Cannabis and Related Substances}. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/01/Cannabis_and_related_substances_A5_final-1.pdf

South African Health Products Regulatory Authority. (2020, February). Frequently Asked Questions: Backlog Type II Deep Dive Survey. Retrieved April 5, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/02/Type-II-FAQ_v1-07-February-2020-.pdf

South African Health Products Regulatory Authority. (2020, February). SAHPRA - Industry Communication FAQs. Retrieved April 5, 2020 from http://www.sahpra.org.za/wp-content/uploads/2020/03/SAHPRA-Industry-Communication-New-FAQs_H1_v1-Feb20.pdf

South African Health Products Regulatory Authority. (2020, February 28). SAHPRA represented at the commission on narcotic drugs (CND) 63rd session in Vienna. Retrieved April 5, 2020 from http://www.sahpra.org.za/wp-content/uploads/2020/03/UNODC-1.pdf

South African Health Products Regulatory Authority. (2020, July). Strategic Plan 2020-2024: Cultivating a High Performance Culture, For a Streamlined Health Products Regulator. Retrieved August 25, 2020 from https://www.sahpra.org.za/wp-content/uploads/2020/07/SAHPRA-Strategic-Plan-2020-22_V4-18320.pdf

South African legislative overview. (2020, February). Norton Rose Fulbright. Retrieved April 18, 2020 from https://www.nortonrosefulbright.com/en-za/knowledge/publications/f57eb1e2/south-african-legislative-overview

The South African pharmaceutical regulatory environment. (2018, June 20). Retrieved April 18, 2020 from https://www.hoganlovells.com/en/publications/the-south-african-pharmaceutical-regulatory-environment

U.S. Department of State. (n.d.). 2019 Investment Climate Statements: South Africa. Retrieved April 5, 2020 from https://www.state.gov/reports/2019-investment-climate-statements/south-africa/

Downloads

Published

2021-06-21 — Updated on 2021-06-24

Versions

Issue

Section

Review Articles